aluates Reports

$ 0.0

Automative

Global Tinea Corporis Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-26N14963

Global Tinea Corporis Treatment Market Insights Forecast to 2029

BUY CHAPTERS

Global Tinea Corporis Treatment Market Research Report 2025

Code: QYRE-Auto-26N14963

Report

March 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Perrigo Company

Glenmark Pharmaceuticals, Inc.

Breckenridge Pharmaceutical, Inc.

NorthStar Rx LLC

Aurobindo Pharma Limited

Camber Pharmaceuticals, Inc.

Avkare

Novartis

Sebela Pharmaceuticals Inc

Bayer

Blueberry Therapeutics Ltd

Taro Pharmaceuticals U.S.A., Inc

Teva Pharmaceuticals Inc

Tinea Corporis Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tinea Corporis Treatment Market

The global market for Tinea Corporis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Tinea corporis treatment refers to the medical and therapeutic approaches used to manage and resolve a fungal skin infection known as tinea corporis, commonly referred to as ringworm. Despite its name, ringworm is not caused by a worm but by various types of dermatophyte fungi, such as Trichophyton or Microsporum, which infect the outer layers of the skin.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Tinea Corporis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tinea Corporis Treatment.

The Tinea Corporis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tinea Corporis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tinea Corporis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tinea Corporis Treatment Market Report

Report Metric	Details
Report Name	Tinea Corporis Treatment Market
CAGR	5%
Segment by Type	Topical Oral
Segment by Application	Hospital Pharmacy Retail Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc., AvKare, Inc., Novartis AG, Sebela Pharmaceuticals, Inc., Bayer AG, Blueberry Therapeutics Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tinea Corporis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tinea Corporis Treatment Market report?

Ans: The main players in the Tinea Corporis Treatment Market are Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc., AvKare, Inc., Novartis AG, Sebela Pharmaceuticals, Inc., Bayer AG, Blueberry Therapeutics Ltd

What are the Application segmentation covered in the Tinea Corporis Treatment Market report?

Ans: The Applications covered in the Tinea Corporis Treatment Market report are Hospital Pharmacy, Retail Pharmacy, Others

What are the Type segmentation covered in the Tinea Corporis Treatment Market report?

Ans: The Types covered in the Tinea Corporis Treatment Market report are Topical, Oral

Recommended Reports

Fungal Infection Treatments

Skin Disease Treatments

Parasitic & Rare Conditions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tinea Corporis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Topical

1.2.3 Oral

1.3 Market by Application

1.3.1 Global Tinea Corporis Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tinea Corporis Treatment Market Perspective (2020-2031)

2.2 Global Tinea Corporis Treatment Growth Trends by Region

2.2.1 Global Tinea Corporis Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tinea Corporis Treatment Historic Market Size by Region (2020-2025)

2.2.3 Tinea Corporis Treatment Forecasted Market Size by Region (2026-2031)

2.3 Tinea Corporis Treatment Market Dynamics

2.3.1 Tinea Corporis Treatment Industry Trends

2.3.2 Tinea Corporis Treatment Market Drivers

2.3.3 Tinea Corporis Treatment Market Challenges

2.3.4 Tinea Corporis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tinea Corporis Treatment Players by Revenue

3.1.1 Global Top Tinea Corporis Treatment Players by Revenue (2020-2025)

3.1.2 Global Tinea Corporis Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Tinea Corporis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tinea Corporis Treatment Revenue

3.4 Global Tinea Corporis Treatment Market Concentration Ratio

3.4.1 Global Tinea Corporis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tinea Corporis Treatment Revenue in 2024

3.5 Global Key Players of Tinea Corporis Treatment Head office and Area Served

3.6 Global Key Players of Tinea Corporis Treatment, Product and Application

3.7 Global Key Players of Tinea Corporis Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tinea Corporis Treatment Breakdown Data by Type

4.1 Global Tinea Corporis Treatment Historic Market Size by Type (2020-2025)

4.2 Global Tinea Corporis Treatment Forecasted Market Size by Type (2026-2031)

5 Tinea Corporis Treatment Breakdown Data by Application

5.1 Global Tinea Corporis Treatment Historic Market Size by Application (2020-2025)

5.2 Global Tinea Corporis Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tinea Corporis Treatment Market Size (2020-2031)

6.2 North America Tinea Corporis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tinea Corporis Treatment Market Size by Country (2020-2025)

6.4 North America Tinea Corporis Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tinea Corporis Treatment Market Size (2020-2031)

7.2 Europe Tinea Corporis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tinea Corporis Treatment Market Size by Country (2020-2025)

7.4 Europe Tinea Corporis Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tinea Corporis Treatment Market Size (2020-2031)

8.2 Asia-Pacific Tinea Corporis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tinea Corporis Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Tinea Corporis Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tinea Corporis Treatment Market Size (2020-2031)

9.2 Latin America Tinea Corporis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tinea Corporis Treatment Market Size by Country (2020-2025)

9.4 Latin America Tinea Corporis Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tinea Corporis Treatment Market Size (2020-2031)

10.2 Middle East & Africa Tinea Corporis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Perrigo Company

11.1.1 Perrigo Company Company Details

11.1.2 Perrigo Company Business Overview

11.1.3 Perrigo Company Tinea Corporis Treatment Introduction

11.1.4 Perrigo Company Revenue in Tinea Corporis Treatment Business (2020-2025)

11.1.5 Perrigo Company Recent Development

11.2 Taro Pharmaceuticals U.S.A., Inc.

11.2.1 Taro Pharmaceuticals U.S.A., Inc. Company Details

11.2.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview

11.2.3 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Introduction

11.2.4 Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.2.5 Taro Pharmaceuticals U.S.A., Inc. Recent Development

11.3 Teva Pharmaceuticals, Inc.

11.3.1 Teva Pharmaceuticals, Inc. Company Details

11.3.2 Teva Pharmaceuticals, Inc. Business Overview

11.3.3 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction

11.3.4 Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.3.5 Teva Pharmaceuticals, Inc. Recent Development

11.4 Glenmark Pharmaceuticals Inc.

11.4.1 Glenmark Pharmaceuticals Inc. Company Details

11.4.2 Glenmark Pharmaceuticals Inc. Business Overview

11.4.3 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Introduction

11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.4.5 Glenmark Pharmaceuticals Inc. Recent Development

11.5 Breckenridge Pharmaceutical, Inc.

11.5.1 Breckenridge Pharmaceutical, Inc. Company Details

11.5.2 Breckenridge Pharmaceutical, Inc. Business Overview

11.5.3 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Introduction

11.5.4 Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.5.5 Breckenridge Pharmaceutical, Inc. Recent Development

11.6 NorthStar Rx LLC

11.6.1 NorthStar Rx LLC Company Details

11.6.2 NorthStar Rx LLC Business Overview

11.6.3 NorthStar Rx LLC Tinea Corporis Treatment Introduction

11.6.4 NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2020-2025)

11.6.5 NorthStar Rx LLC Recent Development

11.7 Aurobindo Pharma Limited

11.7.1 Aurobindo Pharma Limited Company Details

11.7.2 Aurobindo Pharma Limited Business Overview

11.7.3 Aurobindo Pharma Limited Tinea Corporis Treatment Introduction

11.7.4 Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2020-2025)

11.7.5 Aurobindo Pharma Limited Recent Development

11.8 Camber Pharmaceuticals, Inc.

11.8.1 Camber Pharmaceuticals, Inc. Company Details

11.8.2 Camber Pharmaceuticals, Inc. Business Overview

11.8.3 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction

11.8.4 Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.8.5 Camber Pharmaceuticals, Inc. Recent Development

11.9 AvKare, Inc.

11.9.1 AvKare, Inc. Company Details

11.9.2 AvKare, Inc. Business Overview

11.9.3 AvKare, Inc. Tinea Corporis Treatment Introduction

11.9.4 AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.9.5 AvKare, Inc. Recent Development

11.10 Novartis AG

11.10.1 Novartis AG Company Details

11.10.2 Novartis AG Business Overview

11.10.3 Novartis AG Tinea Corporis Treatment Introduction

11.10.4 Novartis AG Revenue in Tinea Corporis Treatment Business (2020-2025)

11.10.5 Novartis AG Recent Development

11.11 Sebela Pharmaceuticals, Inc.

11.11.1 Sebela Pharmaceuticals, Inc. Company Details

11.11.2 Sebela Pharmaceuticals, Inc. Business Overview

11.11.3 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction

11.11.4 Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025)

11.11.5 Sebela Pharmaceuticals, Inc. Recent Development

11.12 Bayer AG

11.12.1 Bayer AG Company Details

11.12.2 Bayer AG Business Overview

11.12.3 Bayer AG Tinea Corporis Treatment Introduction

11.12.4 Bayer AG Revenue in Tinea Corporis Treatment Business (2020-2025)

11.12.5 Bayer AG Recent Development

11.13 Blueberry Therapeutics Ltd

11.13.1 Blueberry Therapeutics Ltd Company Details

11.13.2 Blueberry Therapeutics Ltd Business Overview

11.13.3 Blueberry Therapeutics Ltd Tinea Corporis Treatment Introduction

11.13.4 Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2020-2025)

11.13.5 Blueberry Therapeutics Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Perrigo Company

Glenmark Pharmaceuticals, Inc.

Breckenridge Pharmaceutical, Inc.

NorthStar Rx LLC

Aurobindo Pharma Limited

Camber Pharmaceuticals, Inc.

Avkare

Novartis

Sebela Pharmaceuticals Inc

Bayer

Blueberry Therapeutics Ltd

Taro Pharmaceuticals U.S.A., Inc

Teva Pharmaceuticals Inc

List of Tables

Table 1. Global Tinea Corporis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Topical

Table 3. Key Players of Oral

Table 4. Global Tinea Corporis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Tinea Corporis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Tinea Corporis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Tinea Corporis Treatment Market Share by Region (2020-2025)

Table 8. Global Tinea Corporis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Tinea Corporis Treatment Market Share by Region (2026-2031)

Table 10. Tinea Corporis Treatment Market Trends

Table 11. Tinea Corporis Treatment Market Drivers

Table 12. Tinea Corporis Treatment Market Challenges

Table 13. Tinea Corporis Treatment Market Restraints

Table 14. Global Tinea Corporis Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Tinea Corporis Treatment Market Share by Players (2020-2025)

Table 16. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2024)

Table 17. Ranking of Global Top Tinea Corporis Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Tinea Corporis Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Tinea Corporis Treatment, Headquarters and Area Served

Table 20. Global Key Players of Tinea Corporis Treatment, Product and Application

Table 21. Global Key Players of Tinea Corporis Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tinea Corporis Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Tinea Corporis Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Tinea Corporis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Tinea Corporis Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Tinea Corporis Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Tinea Corporis Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Tinea Corporis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Tinea Corporis Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Tinea Corporis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Tinea Corporis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Tinea Corporis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Tinea Corporis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Tinea Corporis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Tinea Corporis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Tinea Corporis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Perrigo Company Company Details

Table 47. Perrigo Company Business Overview

Table 48. Perrigo Company Tinea Corporis Treatment Product

Table 49. Perrigo Company Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 50. Perrigo Company Recent Development

Table 51. Taro Pharmaceuticals U.S.A., Inc. Company Details

Table 52. Taro Pharmaceuticals U.S.A., Inc. Business Overview

Table 53. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product

Table 54. Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 55. Taro Pharmaceuticals U.S.A., Inc. Recent Development

Table 56. Teva Pharmaceuticals, Inc. Company Details

Table 57. Teva Pharmaceuticals, Inc. Business Overview

Table 58. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product

Table 59. Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 60. Teva Pharmaceuticals, Inc. Recent Development

Table 61. Glenmark Pharmaceuticals Inc. Company Details

Table 62. Glenmark Pharmaceuticals Inc. Business Overview

Table 63. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product

Table 64. Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 65. Glenmark Pharmaceuticals Inc. Recent Development

Table 66. Breckenridge Pharmaceutical, Inc. Company Details

Table 67. Breckenridge Pharmaceutical, Inc. Business Overview

Table 68. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product

Table 69. Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 70. Breckenridge Pharmaceutical, Inc. Recent Development

Table 71. NorthStar Rx LLC Company Details

Table 72. NorthStar Rx LLC Business Overview

Table 73. NorthStar Rx LLC Tinea Corporis Treatment Product

Table 74. NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 75. NorthStar Rx LLC Recent Development

Table 76. Aurobindo Pharma Limited Company Details

Table 77. Aurobindo Pharma Limited Business Overview

Table 78. Aurobindo Pharma Limited Tinea Corporis Treatment Product

Table 79. Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 80. Aurobindo Pharma Limited Recent Development

Table 81. Camber Pharmaceuticals, Inc. Company Details

Table 82. Camber Pharmaceuticals, Inc. Business Overview

Table 83. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product

Table 84. Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 85. Camber Pharmaceuticals, Inc. Recent Development

Table 86. AvKare, Inc. Company Details

Table 87. AvKare, Inc. Business Overview

Table 88. AvKare, Inc. Tinea Corporis Treatment Product

Table 89. AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 90. AvKare, Inc. Recent Development

Table 91. Novartis AG Company Details

Table 92. Novartis AG Business Overview

Table 93. Novartis AG Tinea Corporis Treatment Product

Table 94. Novartis AG Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 95. Novartis AG Recent Development

Table 96. Sebela Pharmaceuticals, Inc. Company Details

Table 97. Sebela Pharmaceuticals, Inc. Business Overview

Table 98. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Product

Table 99. Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 100. Sebela Pharmaceuticals, Inc. Recent Development

Table 101. Bayer AG Company Details

Table 102. Bayer AG Business Overview

Table 103. Bayer AG Tinea Corporis Treatment Product

Table 104. Bayer AG Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 105. Bayer AG Recent Development

Table 106. Blueberry Therapeutics Ltd Company Details

Table 107. Blueberry Therapeutics Ltd Business Overview

Table 108. Blueberry Therapeutics Ltd Tinea Corporis Treatment Product

Table 109. Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2020-2025) & (US$ Million)

Table 110. Blueberry Therapeutics Ltd Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Tinea Corporis Treatment Picture

Figure 2. Global Tinea Corporis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tinea Corporis Treatment Market Share by Type: 2024 VS 2031

Figure 4. Topical Features

Figure 5. Oral Features

Figure 6. Global Tinea Corporis Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Tinea Corporis Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Others Case Studies

Figure 11. Tinea Corporis Treatment Report Years Considered

Figure 12. Global Tinea Corporis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Tinea Corporis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Tinea Corporis Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Tinea Corporis Treatment Market Share by Players in 2024

Figure 16. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Tinea Corporis Treatment Revenue in 2024

Figure 18. North America Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Tinea Corporis Treatment Market Share by Country (2020-2031)

Figure 20. United States Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Tinea Corporis Treatment Market Share by Country (2020-2031)

Figure 24. Germany Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Tinea Corporis Treatment Market Share by Region (2020-2031)

Figure 32. China Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Tinea Corporis Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Tinea Corporis Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Tinea Corporis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Perrigo Company Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 48. Taro Pharmaceuticals U.S.A., Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 49. Teva Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 50. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 51. Breckenridge Pharmaceutical, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 52. NorthStar Rx LLC Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 53. Aurobindo Pharma Limited Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 54. Camber Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 55. AvKare, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 56. Novartis AG Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 57. Sebela Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 58. Bayer AG Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 59. Blueberry Therapeutics Ltd Revenue Growth Rate in Tinea Corporis Treatment Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Fungal Drugs for Treatment of Tinea Market Research Report 2025

Global Sporothrix Schenckii Infection Treatment Market Research Report 2024

Global Tinea Corporis Drugs Market Research Report 2024

Ringworm Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dermatophytosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Surgical Treatment of Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dermatophytosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Dermatomycosis Treatment Market Research Report 2025

Global Onychomycosis Drugs Market Research Report 2024

Athletes Foot Tinea pedis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dermatophytic Onychomycosis Therapeutics DOT Market Research Report 2024

Global Antifungal Drugs for Skin Market Research Report 2024

Treatmet of Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fungal Foot Drugs Market Insights Forecast to 2030

Global Fungal Keratitis Treatment Market Research Report 2024

Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025

Onychomycosis Tinea Unguium Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fungal Nail Infections Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti fungal Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions